SE9401174D0 - New combination - Google Patents

New combination

Info

Publication number
SE9401174D0
SE9401174D0 SE9401174A SE9401174A SE9401174D0 SE 9401174 D0 SE9401174 D0 SE 9401174D0 SE 9401174 A SE9401174 A SE 9401174A SE 9401174 A SE9401174 A SE 9401174A SE 9401174 D0 SE9401174 D0 SE 9401174D0
Authority
SE
Sweden
Prior art keywords
pct
receptor blocker
date
sec
beta
Prior art date
Application number
SE9401174A
Other languages
English (en)
Inventor
Arne Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9401174A priority Critical patent/SE9401174D0/sv
Publication of SE9401174D0 publication Critical patent/SE9401174D0/sv
Priority to IL11307795A priority patent/IL113077A0/xx
Priority to ES95916068T priority patent/ES2189828T3/es
Priority to EP95916068A priority patent/EP0754060B1/en
Priority to JP52627295A priority patent/JP3895767B2/ja
Priority to PCT/SE1995/000314 priority patent/WO1995027511A1/en
Priority to AT95916068T priority patent/ATE233572T1/de
Priority to CA002186601A priority patent/CA2186601C/en
Priority to DE69529819T priority patent/DE69529819T2/de
Priority to DK95916068T priority patent/DK0754060T3/da
Priority to AU22697/95A priority patent/AU689577B2/en
Priority to ZA952724A priority patent/ZA952724B/xx
Priority to US08/428,170 priority patent/US5856342A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE9401174A 1994-04-07 1994-04-07 New combination SE9401174D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9401174A SE9401174D0 (sv) 1994-04-07 1994-04-07 New combination
IL11307795A IL113077A0 (en) 1994-04-07 1995-03-22 New combination of a beta - receptor blocker and alocal anaesthetic
AU22697/95A AU689577B2 (en) 1994-04-07 1995-03-24 New combination of a beta -receptor blocker and a local anaesthetic
JP52627295A JP3895767B2 (ja) 1994-04-07 1995-03-24 β−受容体ブロッカーおよび局所麻酔剤の新規な組合せ
EP95916068A EP0754060B1 (en) 1994-04-07 1995-03-24 New combination of a beta-receptor blocker and a local anaesthetic
ES95916068T ES2189828T3 (es) 1994-04-07 1995-03-24 Nueva combinacion de un agente bloqueador de receptores b y un anestesico local.
PCT/SE1995/000314 WO1995027511A1 (en) 1994-04-07 1995-03-24 NEW COMBINATION OF A β-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC
AT95916068T ATE233572T1 (de) 1994-04-07 1995-03-24 Neue kombination eines betablockers mit einem lokalanästhetikum
CA002186601A CA2186601C (en) 1994-04-07 1995-03-24 New combination of a .beta.-receptor blocker and a local anaesthetic
DE69529819T DE69529819T2 (de) 1994-04-07 1995-03-24 Neue kombination eines betablockers mit einem lokalanästhetikum
DK95916068T DK0754060T3 (da) 1994-04-07 1995-03-24 Ny kombination af en beat-receptorblokker og et lokalanaestetikum
ZA952724A ZA952724B (en) 1994-04-07 1995-04-03 New combination of a beta-receptor blocker and a local anaesthetic
US08/428,170 US5856342A (en) 1994-04-07 1995-04-24 Combination of a β-receptor blocker and a local anaesthetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401174A SE9401174D0 (sv) 1994-04-07 1994-04-07 New combination

Publications (1)

Publication Number Publication Date
SE9401174D0 true SE9401174D0 (sv) 1994-04-07

Family

ID=20393568

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401174A SE9401174D0 (sv) 1994-04-07 1994-04-07 New combination

Country Status (12)

Country Link
US (1) US5856342A (sv)
EP (1) EP0754060B1 (sv)
JP (1) JP3895767B2 (sv)
AT (1) ATE233572T1 (sv)
AU (1) AU689577B2 (sv)
DE (1) DE69529819T2 (sv)
DK (1) DK0754060T3 (sv)
ES (1) ES2189828T3 (sv)
IL (1) IL113077A0 (sv)
SE (1) SE9401174D0 (sv)
WO (1) WO1995027511A1 (sv)
ZA (1) ZA952724B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046588A2 (en) * 1997-04-11 1998-10-22 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
SE9800139D0 (sv) 1998-01-21 1998-01-21 Astra Ab New use
JP4494594B2 (ja) * 2000-06-16 2010-06-30 ナガセ医薬品株式会社 鎮痛剤
JP4816083B2 (ja) * 2003-08-08 2011-11-16 小野薬品工業株式会社 短時間型β遮断薬を有効成分とする心拍数減少剤
ES2224899B1 (es) * 2004-10-20 2006-03-16 Ingenieria De Encofrados Y Servicios, S.L. Cierre lateral para andamio de fachada.
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1806400A1 (de) * 1968-10-31 1970-05-21 Espe Pharm Praep Pharmazeutisches Produkt,insbesondere injizierbares Lakalanaesthetikum
US5496811A (en) * 1992-08-28 1996-03-05 Pharmos Corp. Submicron emulsions as ocular drug delivery vehicles

Also Published As

Publication number Publication date
JP3895767B2 (ja) 2007-03-22
DE69529819T2 (de) 2004-02-12
JPH09511519A (ja) 1997-11-18
DE69529819D1 (de) 2003-04-10
US5856342A (en) 1999-01-05
ZA952724B (en) 1995-10-09
ES2189828T3 (es) 2003-07-16
AU689577B2 (en) 1998-04-02
IL113077A0 (en) 1995-06-29
EP0754060A1 (en) 1997-01-22
DK0754060T3 (da) 2003-04-22
EP0754060B1 (en) 2003-03-05
WO1995027511A1 (en) 1995-10-19
AU2269795A (en) 1995-10-30
ATE233572T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
DK0767669T3 (da) Nyt farmaceutisk præparat til smertebehandling
SE9601421D0 (sv) New composition
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
NO2012003I2 (no) 4-aminopyridin
SE9401174D0 (sv) New combination
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
IL131084A0 (en) The use of levobupivacaine in facial surgery
TW261532B (sv)
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
SE9303324D0 (sv) Operationslakan
DE69427116T2 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU2976095A (en) Use of selegilin in the treatment of epileptic conditions
SE9403861D0 (sv) Novel medicinal use
CA2186601A1 (en) New combination of a .beta.-receptor blocker and a local anaesthetic
Bedson The ring and the book; Browning, poetic voice, the question of" objectivity".